Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune Hepatitis
- 1 October 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Gastroenterology
- Vol. 38 (9), 805-809
- https://doi.org/10.1097/01.mcg.0000139050.67178.be
Abstract
Autoimmune hepatitis (AIH) is an immune mediated chronic liver disease with a prevalence of 17 cases/100,000. Resistance to the standard treatment of AIH (prednisone and azathioprine) occurs in 15% to 20%. There is currently no standard treatment of patients with steroid refractory AIH. Determine the efficacy of tacrolimus in the treatment of steroid refractory AIH. This is a retrospective study evaluating the efficacy of Tacrolimus in the treatment of steroid refractory AIH. Between October 1998 and February 2002, 11 patients with steroid refractory AIH were treated with tacrolimus. Mean age was 63 years. Median duration of steroid treatment before starting tacrolimus was 9 months. Median duration of tacrolimus treatment was 25 months. Median follow-up period was 16 months. Median baseline ALT, AST were 77 U/L and 68 U/L and became 21 U/L and 32 U/L respectively at end of follow-up (P = 0.005 and 0.01 respectively). Significant weight reduction was seen in all patients (P = 0.02). Tacrolimus treatment was safe and well tolerated. Use of low dose tacrolimus led to successful biochemical and histologic remission and weaning off prednisone in patients with steroid refractory AIH. This data supports further studies in evaluating the use of tacrolimus in the treatment of AIH.Keywords
This publication has 16 references indexed in Scilit:
- Current and novel immunosuppressive therapy for autoimmune hepatitisHepatology, 2002
- Current Concepts in the Diagnosis, Pathogenesis, and Treatment of Autoimmune HepatitisMayo Clinic Proceedings, 2001
- Autoimmune hepatitis: The investigational and clinical challengesHepatology, 2000
- Autoimmune Liver Disease. Current Therapy.Internal Medicine, 2000
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Short-term cyclosporine induces a remission of autoimmune hepatitis in childrenJournal of Hepatology, 1999
- Cyclosporine Therapy in Patients With Steroid Resistant Autoimmune HepatitisThe American Journal of Gastroenterology, 1999
- Drug Therapy in the Management of Type 1 Autoimmune HepatitisDrugs, 1999
- Incidence and Prevalence of Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis in a Norwegian PopulationScandinavian Journal of Gastroenterology, 1998
- Corticosteroid-Treated Chronic Active Hepatitis in RemissionNew England Journal of Medicine, 1981